Glasgow/Wetlab/Biobricks

From 2007.igem.org

(Difference between revisions)
(BioBrick Reference)
(BioBrick Reference)
Line 3: Line 3:
== BioBrick Reference ==
== BioBrick Reference ==
{| border="1" cellspacing="0" cellpadding="5" align="center"
{| border="1" cellspacing="0" cellpadding="5" align="center"
 +
!Number
!Label
!Label
!Plate
!Plate
Line 9: Line 10:
!Plasmid
!Plasmid
!Resistance
!Resistance
-
!
+
!V
!Description
!Description
 +
!Results
|-
|-
 +
|1
|4/7A
|4/7A
|4
|4
Line 20: Line 23:
|
|
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|2
|4/11E
|4/11E
|4
|4
Line 29: Line 34:
|
|
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|
|4/11C
|4/11C
|4
|4
Line 38: Line 45:
|
|
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|3
|2/23N
|2/23N
|2
|2
Line 47: Line 56:
|V1005
|V1005
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|4
|2/21B
|2/21B
|2
|2
Line 55: Line 66:
|Carbenicillin
|Carbenicillin
|V1005
|V1005
-
|Death gene plasmid
+
|Death gene plasmid|
|-
|-
 +
|5
|2/23P
|2/23P
|2
|2
Line 65: Line 77:
|V1005
|V1005
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|6
|2/2B
|2/2B
|2
|2
Line 74: Line 88:
|V1005
|V1005
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|7
|2/6J
|2/6J
|2
|2
Line 83: Line 99:
|V1005
|V1005
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|8
|2/12J
|2/12J
|2
|2
Line 92: Line 110:
|V1005
|V1005
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|9
|3/20G
|3/20G
|3
|3
Line 101: Line 121:
|V1015
|V1015
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|10
|3/20I
|3/20I
|3
|3
Line 110: Line 132:
|V1015
|V1015
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|11
|5/6B
|5/6B
|5
|5
Line 119: Line 143:
|
|
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|12
|5/6C
|5/6C
|5
|5
Line 128: Line 154:
|
|
|Death gene plasmid
|Death gene plasmid
 +
|
|-
|-
 +
|13
|4/5I
|4/5I
|4
|4
Line 137: Line 165:
|
|
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|14
|4/5O
|4/5O
|4
|4
Line 146: Line 176:
|
|
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|15
|4/6B
|4/6B
|4
|4
Line 155: Line 187:
|
|
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|16
|4/6D
|4/6D
|4
|4
Line 163: Line 197:
|Kanamycin
|Kanamycin
|
|
-
|High copy death gene
+
|High copy death gene|
|-
|-
 +
|17
|4/6F
|4/6F
|4
|4
Line 173: Line 208:
|
|
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|18
|4/5K
|4/5K
|4
|4
Line 182: Line 219:
|
|
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|19
|4/5M
|4/5M
|4
|4
Line 191: Line 230:
|
|
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|20
|4/4J
|4/4J
|4
|4
Line 199: Line 240:
|Chloramphenicol
|Chloramphenicol
|V1009
|V1009
-
|High copy death gene
+
|High copy death gene|
|-
|-
 +
|21
|4/4L
|4/4L
|4
|4
Line 209: Line 251:
|V1009
|V1009
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|22
|4/4N
|4/4N
|4
|4
Line 218: Line 262:
|V1009
|V1009
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|23
|4/4P
|4/4P
|4
|4
Line 227: Line 273:
|V1009
|V1009
|High copy death gene
|High copy death gene
 +
|
|-
|-
 +
|24
|3/19A
|3/19A
|3
|3
Line 236: Line 284:
|V1013
|V1013
|Strong constitutive promoter
|Strong constitutive promoter
 +
|
|-
|-
 +
|25
|1/9G
|1/9G
|1
|1
Line 245: Line 295:
|V1004
|V1004
|HSL + LuxR Inducible
|HSL + LuxR Inducible
 +
|
|-
|-
 +
|26
|1/16P
|1/16P
|1
|1
Line 254: Line 306:
|V1009
|V1009
|IPTG: inducible promoter + RBS
|IPTG: inducible promoter + RBS
 +
|
|-
|-
 +
|27
|1/5H
|1/5H
|1
|1
Line 263: Line 317:
|V100
|V100
|GFP mutant no promoter (3b)
|GFP mutant no promoter (3b)
 +
|
|-
|-
 +
|28
|1/1G
|1/1G
|1
|1
Line 272: Line 328:
|
|
|Double terminator
|Double terminator
 +
|
|-
|-
 +
|29
|1/1I
|1/1I
|1
|1
Line 281: Line 339:
|
|
|Double terminator
|Double terminator
 +
|
|-
|-
 +
|30
|3/3O
|3/3O
|3
|3
Line 290: Line 350:
|
|
|Double terminator
|Double terminator
 +
|
|-
|-
 +
|31
|4/12N
|4/12N
|4
|4
Line 299: Line 361:
|
|
|RBSes
|RBSes
 +
|
|-
|-
 +
|32
|4/12J
|4/12J
|4
|4
Line 308: Line 372:
|
|
|RBSes
|RBSes
 +
|
|-
|-
 +
|33
|4/12L
|4/12L
|4
|4
Line 317: Line 383:
|
|
|RBSes
|RBSes
 +
|
|-
|-
 +
|34
|4/12P
|4/12P
|4
|4
Line 326: Line 394:
|
|
|RBSes
|RBSes
 +
|
|-
|-
 +
|35
|1/11A
|1/11A
|1
|1
Line 335: Line 405:
|
|
|EYFP,RBS + terminator
|EYFP,RBS + terminator
 +
|
|-
|-
 +
|36
|1/11G
|1/11G
|1
|1
Line 344: Line 416:
|
|
|ECFP, RBS, Term, +LVA TAG
|ECFP, RBS, Term, +LVA TAG
 +
|
|-
|-
 +
|37
|1/11C
|1/11C
|1
|1
Line 353: Line 427:
|
|
|EYFP, RBS, Term, + LVA TAG
|EYFP, RBS, Term, + LVA TAG
 +
|
|}
|}

Revision as of 17:52, 16 August 2007

Glasgow Main Page


BioBrick Reference

Number Label Plate Location Brick Plasmid Resistance V Description Results
1 4/7A 4 7A BBa_p1010 pSB1A10 Carbenicillin Death gene plasmid
2 4/11E 4 11E BBa_p1010 pSB1A10 Carbenicillin Death gene plasmid
4/11C 4 11C BBa_p1010 pSB3K3 Kanamycin Death gene plasmid
3 2/23N 2 23N BBa_p1010 pSB1AK3 Carbenicillin/ Kanamycin V1005 Death gene plasmid
4 2/21B 2 21B BBa_p1010 pSB1AC3 Carbenicillin V1005
5 2/23P 2 23P BBa_p1010 pSB1AT3 Carbenicillin/Tetracycline V1005 Death gene plasmid
6 2/2B 2 2B BBa_p1010 pSB1AC3 Chloramphenicol V1005 Death gene plasmid
7 2/6J 2 6J BBa_p1010 pSB4A3 Carbenicillin V1005 Death gene plasmid
8 2/12J 2 12J BBa_p1010 pSB2K3 Kanamycin V1005 Death gene plasmid
9 3/20G 3 20G BBa_p1010 pSB1A2 Carbenicillin V1015 Death gene plasmid
10 3/20I 3 20I BBa_p1010 pSB1A3 Carbenicillin V1015 Death gene plasmid
11 5/6B 5 6B BBa_p1010 pSB3K3 Kanamycin Death gene plasmid
12 5/6C 5 6C BBa_p1010 pSB1A10 Carbenicillin Death gene plasmid
13 4/5I 4 5I BBa_I52001 pSB4A5 Carbenicillin High copy death gene
14 4/5O 4 5O BBa_I52001 pSB4K5 Kanamycin High copy death gene
15 4/6B 4 6B BBa_I52001 pSB3K5 Kanamycin High copy death gene
16 4/6D 4 6D BBa_I52001 pSB4K5 Kanamycin
17 4/6F 4 6F BBa_I52001 pSB4A5 Carbenicillin High copy death gene
18 4/5K 4 5K BBa_I52001 pSB4C5 Chloramphenicol High copy death gene
19 4/5M 4 5M BBa_I52001 pSB4T5 Tetracycline High copy death gene
20 4/4J 4 4J BBa_I52001 pSB3C5 Chloramphenicol V1009
21 4/4L 4 4L BBa_I52001 pSB4C5 Chloramphenicol V1009 High copy death gene
22 4/4N 4 4N BBa_I52001 pSB3T5 Tetracylcine V1009 High copy death gene
23 4/4P 4 4P BBa_I52001 pSB4T5 Tetracycline V1009 High copy death gene
24 3/19A 3 19/A BBa_J23119 pSB1A2 Carbenicillin V1013 Strong constitutive promoter
25 1/9G 1 9G BBa_R0062 pSB1A2 Carbenicillin V1004 HSL + LuxR Inducible
26 1/16P 1 16P BBa_J04500 pSB1AK3 Carbenicillin/Kanamycin V1009 IPTG: inducible promoter + RBS
27 1/5H 1 5H BBa_E0040 pSB1A2 Carbenicillin V100 GFP mutant no promoter (3b)
28 1/1G 1 1G BBa_B0014 pSB1AK3 Carbenicillin/Kanamycin Double terminator
29 1/1I 1 1I BBa_B0015 pSB1AK3 Carbenicillin/Kanamycin Double terminator
30 3/3O 3 3O BBa_B0015 pSB1AK3 Carbenicillin/Kanamycin Double terminator
31 4/12N 4 12N BBa_J6110/J61103 pSB1A2 Carbenicillin RBSes
32 4/12J 4 12J BBa_J6110/J61103 pSB1A2 Carbenicillin RBSes
33 4/12L 4 12L BBa_J6110/J61103 pSB1A2 Carbenicillin RBSes
34 4/12P 4 12P BBa_J6110/J61103 pSB1A2 Carbenicillin RBSes
35 1/11A 1 11A BBa_E0430 pSB1A2 Carbenicillin EYFP,RBS + terminator
36 1/11G 1 11G BBa_E0422 pSB1A2 Carbenicillin ECFP, RBS, Term, +LVA TAG
37 1/11C 1 11C BBa_E0432 pSB1A2 Carbenicillin EYFP, RBS, Term, + LVA TAG